The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations
Open accessAbstract
Increased exposure of phosphatidylserine (PS) in erythrocytes has been postulated to contribute to the pathophysiology of sickle cell disease because of its possible effects on blood coagulation, cell adhesion, and cell clearance. We developed a flow-cytometric assay to measure exposure of PS on the outer face of the erythrocyte membrane based on addition of fluorescein-annexin V to whole-blood specimens. The assay correlated linearly with binding of 125I-annexin V (r2 = .95, n = 125 samples). Normal donors (n = 30) showed virtually no annexin-positive cells (0.34% +/- 0.18% for 24-hour old samples). In contrast, annexin V binding was above the upper limit of normal in 96% of 205 specimens from 17 adult sickle cell and 2 beta-thalassemia patients; the mean percentage of annexin-positive cells was 2.86% +/- 2.00% (range, 0.4% to 12.0%). Values varied substantially over time for some patients, and mean values varied between patients. The percentage of annexin-positive cells always decreased after transfusion (11 events in 6 patients), and out of proportion to the amount of blood transfused. In conclusion, increased exposure of PS on a subpopulation of erythrocytes in vivo is a virtually universal feature of sickle cell disease, and its measurement may be useful to evaluate clinical status and response to therapeutic measures such as blood transfusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, PS exposure on RBCs is increased in SCD (195).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koopman, G., Reutelingsperger, C. P. M., Kuijten, G., Keehnen, R. M. J., Pals, S. T., & van Oers, M. H. J. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,687
Raynal, P., & Pollard, H. B. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(94)90019-1 · Cited by 1,115
Marchesi, V. T., Furthmayr, H., & Tomita, M. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.003315 · Cited by 590
Homburg, C., de Haas, M., Borne, A. E. G. K. V. D., Verhoeven, A. J., Reutelingsperger, C. P. M., & Roos, D. (1995) · Blood · doi:10.1182/blood.v85.2.532.532 · Cited by 431
Abnormal Adherence of Sickle Erythrocytes to Cultured Vascular Endothelium
Hebbel, R. P., Yamada, O., Moldow, C. F., Jacob, H. S., White, J. G., & Eaton, J. W. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109646 · Cited by 421
Thiagarajan, P., & Tait, J. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38177-8 · Cited by 376
Self-citationSatta, N., Toti, F., Feugeas, O., Bohbot, A., Dachary-Prigent, J., Eschwège, V., Hedman, H., & Freyssinet, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.7.3245 · Cited by 372
Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology
Hebbel, R. (1991) · Blood · doi:10.1182/blood.v77.2.214.bloodjournal772214 · Cited by 365
Dachary-Prigent, J., Freyssinet, J., Pasquet, J., Carron, J., & Nurden, A. T. (1993) · Blood · doi:10.1182/blood.v81.10.2554.2554 · Cited by 352
Schroit, A. J., Madsen, J. W., & Tanaka, Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89189-x · Cited by 349
Flagged first, then by citations
Cited by
Sorted by citations
Red cell membrane: past, present, and future
Mohandas, N., & Gallagher, P. G. (2008) · Blood · doi:10.1182/blood-2008-07-161166 · Cited by 1,089
Surface exposure of phosphatidylserine in pathological cells
Zwaal, R. F. A., Comfurius, P., & Bevers, E. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4527-3 · Cited by 753
Apoptotic Vascular Endothelial Cells Become Procoagulant
Bombeli, T., Karsan, A., Tait, J. F., & Harlan, J. M. (1997) · Blood · doi:10.1182/blood.v89.7.2429 · Cited by 623
Self-citationIn vivo detection and imaging of phosphatidylserine expression during programmed cell death
Blankenberg, F. G., Katsikis, P. D., Tait, J. F., Davis, R. E., Naumovski, L., Ohtsuki, K., Kopiwoda, S. Y., Abrams, M. J., Darkes, M. C., Robbins, R. C., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6349 · Cited by 537
Self-citationRed Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia
Kuhn, V., Diederich, L., Keller, T. C. S., Kramer, C. M., Lückstädt, W., Panknin, C., Suvorava, T., Isakson, B. E., Kelm, M., & Cortese-Krott, M. M. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6954 · Cited by 469
Metadata
- Authors
- Wood, B., Gibson, D., & Tait, J.
- Affiliations
- University of Washington (US)
- Department of Laboratory Medicine, University of Washington, Seattle 98195–7110, USA.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-09-01
- Volume
- 88
- Issue
- 5
- Pages
- 1873-1880
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W13114315
- Cited by
- 445
- References
- 34
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 2 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 4 · 2019: 2 · 2018: 10 · 2017: 17 · 2016: 33 · 2015: 41 · 2014: 28 · 2013: 31 · 2012: 24
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50hl047151-05)
- National Heart, Lung, and Blood Institute (HL-47151)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Physiology (medical) › Erythrocyte Function and Pathophysiology
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, phosphatidylserine exposure, erythrocytes, annexin V, beta-thalassemia, blood transfusion, flow cytometry assay, cell adhesion, coagulation, cell clearance
- MeSH terms
- Adult, Anemia, Sickle Cell, Erythrocyte Membrane, Erythrocytes, Abnormal, Flow Cytometry, Humans, Membrane Lipids, Phosphatidylserines, beta-Thalassemia, Annexin A5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
